Mirum Pharamceuticals (MIRM) PT Raised to $88 at Raymond James; 'PFIC Readout a Virtual Best Case'
Tweet Send to a Friend
Raymond James analyst Steven Seedhouse raised the price target on Mirum Pharamceuticals (NASDAQ: MIRM) to $88.00 (from $75.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
